Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck & Co Takes Up Astex/Taiho SHP2 Program

Indicates Growing Pharma Interest

Jan 13 2021

• By Ian Haydock

Cancer Research — • Source: Shutterstock

Related Content

Deal Watch: GSK Makes $85m Wager On Surface’s Preclinical NK Cell Therapy

Dec 21 2020

Amgen’s KRAS Inhibitor Shows Durability; Pivotal Data Possible This Year

Sep 22 2020

Deal Watch: Chinook To Go Public Via Reverse Merger With Troubled Aduro

Jun 02 2020

Related Companies

Otsuka Holdings Co., Ltd.

Taiho Pharmaceutical Co. Ltd.

Astex Pharmaceuticals Ltd.

Merck & Co., Inc.

Otsuka Pharmaceutical Co. Ltd.

Moderna, Inc.

Revolution Medicines, Inc.

Amgen, Inc.

Sanofi

Novartis AG

Mirati Therapeutics, Inc.

Jacobio Pharmaceuticals Co. Ltd.

Genentech, Inc.

Relay Therapeutics, Inc.

BridgeBio Pharma, Inc.

Navire Pharma, Inc.

Additional Topics

Deals Research & Development Cancer BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window